|
|
Curt D. Sigmund, PhD
Dr. Sigmund received his undergraduate education at the State
University of New York in Buffalo, NY, and his PhD in Molecular and
Cellular Biology from the same institution. He was originally trained as
a classical bacterial geneticist but recognized how new tools designed
to manipulate the mammalian genome would provide a mechanism to link
genetics and physiology. He sought postdoctoral training in this area
under the mentorship of Kenneth W. Gross at Roswell Park Cancer
Institute and helped establish a collaboration between Dr. Gross and Dr.
Victor J. Dzau to physiologically examine some of the first mice with
genetic alterations in the renin-angiotensin system. In order to
capitalize on the power of genetics and physiology, he accepted a
faculty position in the Cardiovascular Research Center at the University
of Iowa in 1991 where he established a collaboration with Dr. Jean
Robillard, now Dean of the College of Medicine, to measure arterial
pressure in genetically altered mice. Dr. Sigmund is currently a
Professor of Internal Medicine and Molecular Physiology and Biophysics
in the Roy J. and Lucille A. Carver College of Medicine at the
University of Iowa in Iowa City, IA, where he directs the Transgenic
Animal Facility and the Center on the Functional Genomics of
Hypertension
Sigmund’s research initially focused on the molecular biology and
genetics of the renin-angiotensin system and its role in hypertension, and
more recently has been expanded to include the regulation of vascular
function by the ligand activated transcription factors such as PPARγ. His
expertise is on the development of unique mouse models from which to study
these systems in vivo. He has published over 150 papers including, in 1999,
the first research paper published in the APS Journal- Physiological
Genomics. This paper entitled “Novel mechanism of hypertension revealed
by cell-specific targeting of human angiotensinogen in transgenic mice”
provided the first genetic evidence that abnormalities in renal angiotensin-II
levels can cause hypertension even when circulating levels of angiotensin-II
are normal.
Dr. Sigmund has been recognized with research awards from the American
Federation for Medical Research, American Society of Hypertension, and in
2000 received the Henry Pickering Bowditch Award of the American
Physiological Society. Dr. Sigmund will be completing a 6-year term as
Chair of the Joint Program Committee in 2007 and was previously an Associate
Editor of AJP: Endocrinology and Metabolism, Physiological
Genomics and Hypertension, a journal of the American Heart
Association.
Back to AJP - Regulatory, Integrative and
Comparative Physiology home page
|
|
